Prolonged consumption of artificial sweeteners could elevate obesity risks, study finds

A recent study has established a concerning connection between long-term intake of artificial sweeteners such as aspartame and saccharin, as well as diet sodas, and an augmented risk of obesity. The findings were featured in the International Journal of Obesity, following an extensive examination of the relationships between the consumption of these substances and a variety of health parameters.

Undertaken as part of the Coronary Artery Risk Development in Young Adults (CARDIA) initiative, the research embraced a diverse participant group of 5,115 individuals, comprising both black and white men and women. The focal point of the study was to dissect the potential relationships between artificial sweetener and diet beverage consumption and the volumes of visceral adipose tissue (AT), intermuscular AT, and subcutaneous AT, while accounting for demographic factors and lifestyle elements such as total caloric intake and adherence to healthy eating guidelines.

Over a span of 25 years, 3,088 individuals — including 869 black women, 867 white women, 590 black men, and 762 white men aged between 18 and 30 at the onset — were rigorously examined, with their dietary intakes tracked at intervals of the inception, the 7th year, and the 20th year. This meticulous approach allowed for a nuanced breakdown of aspartame and saccharin consumption patterns across quintiles and tertiles, respectively.

Drawing a strong parallel between heightened artificial sweetener intake and expanded volumes of all three types of AT assessed — visceral, subcutaneous, and intermuscular — the study spotlighted worrying trends. Individuals in the uppermost quintile of aspartame consumption demonstrated greater AT volumes in comparison to those in the lowest quintile. Furthermore, higher aspartame intake was associated with pronounced increases in body mass index (BMI), weight, and waist circumference throughout the quarter-century follow-up period.

Similar trends were observed in saccharin consumption, with the highest tertile group reporting up to 14% higher subcutaneous AT alongside substantial augmentations in BMI, weight, and waist circumference. The consumption of diet beverages mirrored these patterns, revealing significant escalations in AT volumes and BMI in those indulging more frequently in these drinks.

Although sucralose intake depicted an upward trajectory in BMI and weight, it remained distinct by not showing a noticeable impact on AT volumes or anthropometric changes over the long-term period studied.

This seminal study foregrounded the alarming implications of prolonged artificial sweetener intake, connecting higher consumption levels with a substantial upswing in obesity risks — with the upper quintiles exhibiting up to a 78% greater propensity for obesity compared to their lower quintile counterparts.

Despite offering unprecedented insights, the research is cognisant of potential limitations including self-reporting biases and the possible influence of altered microbiomes on adipogenesis.

In light of these potent revelations, the researchers advocate a reevaluation of prevailing national advisories encouraging the substitution of added sugars with artificial sweeteners. Highlighting the potential adverse health repercussions of both options, the study calls for a more nuanced approach to fostering healthier dietary choices.